292 related articles for article (PubMed ID: 25176399)
21. Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway.
Wang JR; Li TZ; Wang C; Li SM; Luo YH; Piao XJ; Feng YC; Zhang Y; Xu WT; Zhang Y; Zhang T; Wang SN; Xue H; Wang HX; Cao LK; Jin CH
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1987-1999. PubMed ID: 31956937
[TBL] [Abstract][Full Text] [Related]
22. Oridonin induces G2/M cell cycle arrest and apoptosis through MAPK and p53 signaling pathways in HepG2 cells.
Wang H; Ye Y; Chui JH; Zhu GY; Li YW; Fong DW; Yu ZL
Oncol Rep; 2010 Sep; 24(3):647-51. PubMed ID: 20664969
[TBL] [Abstract][Full Text] [Related]
23. Acetyl-macrocalin B, an ent-kaurane diterpenoid, initiates apoptosis through the ROS-p38-caspase 9-dependent pathway and induces G2/M phase arrest via the Chk1/2-Cdc25C-Cdc2/cyclin B axis in non-small cell lung cancer.
Wang JN; Zhang ZR; Che Y; Yuan ZY; Lu ZL; Li Y; Li N; Wan J; Sun HD; Sun N; Puno PT; He J
Cancer Biol Ther; 2018 Jul; 19(7):609-621. PubMed ID: 29565730
[TBL] [Abstract][Full Text] [Related]
24. 2'-epi-2'-O-Acetylthevetin B extracted from seeds of Cerbera manghas L. induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Feng B; Guo YW; Huang CG; Li L; Chen RH; Jiao BH
Chem Biol Interact; 2010 Jan; 183(1):142-53. PubMed ID: 19874809
[TBL] [Abstract][Full Text] [Related]
25. UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.
Wu G; Lin N; Xu L; Liu B; Feitelson MA
BMC Cancer; 2013 Mar; 13():167. PubMed ID: 23537372
[TBL] [Abstract][Full Text] [Related]
26. The Novel Nature Microtubule Inhibitor Ivalin Induces G2/M Arrest and Apoptosis in Human Hepatocellular Carcinoma SMMC-7721 Cells In Vitro.
Liu F; Lin S; Zhang C; Ma J; Han Z; Jia F; Xie W; Li X
Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31409007
[No Abstract] [Full Text] [Related]
27. Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
Nagappan A; Lee WS; Yun JW; Lu JN; Chang SH; Jeong JH; Kim GS; Jung JM; Hong SC
PLoS One; 2017; 12(3):e0174591. PubMed ID: 28355296
[TBL] [Abstract][Full Text] [Related]
28. 4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway.
Chaudhary P; Sharma R; Sahu M; Vishwanatha JK; Awasthi S; Awasthi YC
J Biol Chem; 2013 Jul; 288(28):20532-46. PubMed ID: 23733185
[TBL] [Abstract][Full Text] [Related]
29. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
30. Induction of G₂/M Arrest by Berberine via Activation of PI3K/Akt and p38 in Human Chondrosarcoma Cell Line.
Eo SH; Kim JH; Kim SJ
Oncol Res; 2014; 22(3):147-57. PubMed ID: 26168133
[TBL] [Abstract][Full Text] [Related]
31. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
Zhang G; He J; Ye X; Zhu J; Hu X; Shen M; Ma Y; Mao Z; Song H; Chen F
Cell Death Dis; 2019 Mar; 10(4):255. PubMed ID: 30874538
[TBL] [Abstract][Full Text] [Related]
32. Calycosin induces mitochondrial-dependent apoptosis and cell cycle arrest, and inhibits cell migration through a ROS-mediated signaling pathway in HepG2 hepatocellular carcinoma cells.
Liu Y; Piao XJ; Xu WT; Zhang Y; Zhang T; Xue H; Li YN; Zuo WB; Sun G; Fu ZR; Luo YH; Jin CH
Toxicol In Vitro; 2021 Feb; 70():105052. PubMed ID: 33188878
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of USP12 inhibits tumor growth via the p38/MAPK pathway in hepatocellular carcinoma.
Liu C; Li X; Feng G; Cao M; Liu F; Zhang G; Lu Y
Mol Med Rep; 2020 Dec; 22(6):4899-4908. PubMed ID: 33174033
[TBL] [Abstract][Full Text] [Related]
34. 14,15β-dihydroxyklaineanone inhibits HepG2 cell proliferation and migration through p38MAPK pathway.
Pei XD; He SQ; Shen LQ; Wei JC; Li XS; Wei YY; Zhang YM; Wang XY; Lin F; He ZL; Jiang LH
J Pharm Pharmacol; 2020 Sep; 72(9):1165-1175. PubMed ID: 32419149
[TBL] [Abstract][Full Text] [Related]
35. Genetically engineered drug rhCNB induces apoptosis and cell cycle arrest in both gastric cancer cells and hepatoma cells.
Guo Y; Huang Y; Tian S; Xie X; Xing G; Fu J
Drug Des Devel Ther; 2018; 12():2567-2575. PubMed ID: 30154649
[TBL] [Abstract][Full Text] [Related]
36. Aloperine induces apoptosis and G2/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K/Akt signaling pathway.
Liu JS; Huo CY; Cao HH; Fan CL; Hu JY; Deng LJ; Lu ZB; Yang HY; Yu LZ; Mo ZX; Yu ZL
Phytomedicine; 2019 Aug; 61():152843. PubMed ID: 31039533
[TBL] [Abstract][Full Text] [Related]
37. Growth arrest induced by C75, A fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma.
Gao Y; Lin LP; Zhu CH; Chen Y; Hou YT; Ding J
Cancer Biol Ther; 2006 Aug; 5(8):978-85. PubMed ID: 16855382
[TBL] [Abstract][Full Text] [Related]
38. Opposite effects of JNK and p38 MAPK signaling pathways on furazolidone-stimulated S phase cell cycle arrest of human hepatoblastoma cell line.
Sun Y; Tang S; Jin X; Zhang C; Zhao W; Xiao X
Mutat Res; 2013 Jul; 755(1):24-9. PubMed ID: 23660333
[TBL] [Abstract][Full Text] [Related]
39. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Wang Y; Dong L; Li J; Luo M; Shang B
Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
[TBL] [Abstract][Full Text] [Related]
40. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
